Skip to main content
I was thrilled that the American College of Rheumatology put together the Community Aging Hub and multiple sessions to help rheumatologists identify gaps in care for older patients with rheumatic diseases. My friend and colleague, Dr. Una Makris, taught me the 5 M’s of aging that should be assessed in our patients.
Vitamin D and Omega-3 Fatty Acids Reduce Risk of Autoimmune Diseases: Dr. Chao ( @doctorRBC) discusses abstract #0957 pr

Dr. John Cush RheumNow

4 years 10 months ago
Vitamin D and Omega-3 Fatty Acids Reduce Risk of Autoimmune Diseases: Dr. Chao ( @doctorRBC) discusses abstract #0957 presented at the #ACR21 annual meeting. https://t.co/h6CpY1Zn2r https://t.co/hebsz6tge3
An Old Friend – Methotrexate in Psoriatic Arthritis

Methotrexate (MTX) remains one of our most used and reliable too

Dr. John Cush RheumNow

4 years 10 months ago
An Old Friend – Methotrexate in Psoriatic Arthritis Methotrexate (MTX) remains one of our most used and reliable tools against a variety of rheumatic diseases, particularly in the care of peripheral arthritis such as PsA. https://t.co/zIsbL3KFlZ #ACR21 @_Castillo_Pedro https://t.co/Efm2kAx85x
Cytokines & Chemokines Predict Incident MACE in RA Veterans: Dr. El Ramahi ( @MeralElRamahiMD) discusses abstract #0

Dr. John Cush RheumNow

4 years 10 months ago
Cytokines & Chemokines Predict Incident MACE in RA Veterans: Dr. El Ramahi ( @MeralElRamahiMD) discusses abstract #0572 presented at the #ACR21 annual meeting. https://t.co/nM2YBuAzMh https://t.co/Pv8tVQOzol
Are you Aware of COPA Syndrome? Dr. Meral El Ramahi ( @MeralElRamahiMD) discusses abstract #0529 at the #ACR21 annual me

Dr. John Cush RheumNow

4 years 10 months ago
Are you Aware of COPA Syndrome? Dr. Meral El Ramahi ( @MeralElRamahiMD) discusses abstract #0529 at the #ACR21 annual meeting. https://t.co/vsOvPV5JQp https://t.co/E7ugLvt5uO
Health Information Use by SLE Patients: Dr. Sheila Reyes ( @RHEUMarampa) discusses abstract #0880 presented at the #ACR2

Dr. John Cush RheumNow

4 years 10 months ago
Health Information Use by SLE Patients: Dr. Sheila Reyes ( @RHEUMarampa) discusses abstract #0880 presented at the #ACR21 annual meeting. https://t.co/48KOK413lO
Twin Studies on Psoriasis Microbiome: Dr. Robert Chao ( @doctorRBC) discusses abstract #0944 presented at the #ACR21 ann

Dr. John Cush RheumNow

4 years 10 months ago
Twin Studies on Psoriasis Microbiome: Dr. Robert Chao ( @doctorRBC) discusses abstract #0944 presented at the #ACR21 annual meeting. https://t.co/NCGkuEkued https://t.co/N03gPIqwvQ
Poverty and Length of Hospital Stays for Children with Lupus: Dr. Bella Mehta ( @bella_mehta) discusses abstract #0768 p

Dr. John Cush RheumNow

4 years 10 months ago
Poverty and Length of Hospital Stays for Children with Lupus: Dr. Bella Mehta ( @bella_mehta) discusses abstract #0768 presented at the #ACR21 annual meeting. https://t.co/86ZTH99QN7 https://t.co/KCAkmmgmsP
Is it time to go back to big F2F conferences? Yes if you get VAX'd, Carded & Temp'd AND you Mask-up, Back-up and Wa

Dr. John Cush RheumNow

4 years 10 months ago
Is it time to go back to big F2F conferences? Yes if you get VAX'd, Carded & Temp'd AND you Mask-up, Back-up and Wash-up! It might could be safe! https://t.co/Ut6LxAEmiT
Filgotinib (Jyseleca) was approved by European Commission approved for EU use in adults with moderately to severely acti

Dr. John Cush RheumNow

4 years 10 months ago
Filgotinib (Jyseleca) was approved by European Commission approved for EU use in adults with moderately to severely active Ulcerative colitis (not responding to conventional therapy or a biologic). Rec based on Phase 2b/3 SELECTION trial. https://t.co/vMGNMKhy34
×